Tris Pharma has announced partnerships with Calm Health and ADHD [...]

Rutgers researchers found that changes in brain network dynamics were [...]

Compass Pathways has published a post hoc analysis of its [...]

Advanced positron emission tomography (PET) imaging has revealed widespread loss [...]

Alto Neuroscience has raised $100 million through an underwritten registered [...]

Compass Pathways has reported positive six-month results from its second [...]

Compass Pathways has reported that its second pivotal Phase 3 [...]

This is a disease awareness paid article sponsored by Sanofi. [...]

Alto Neuroscience has received FDA Fast Track designation for its [...]

Bristol Myers Squibb plans to launch Cobenfy (xanomeline and trospium [...]